Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

543

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

543 results for “Clinical Management,”

Learn how ShareScore rates datasets ↗
zenodo44/100

Clinical evidence for high-risk CE-marked medical devices for glucose management: a systematic review and meta-analysis

<p><strong><span>Aims: </span></strong><span>High-risk medical devices are increasingly used in diabetes management, but<span><span> there are no specific European recommendations on how they should be evaluated. Within</span></span> the Coordinating Research and Evidence for Medical Devices (CORE-MD) project, we conducted a systematic review and meta-analysis evaluating CE-marked high-risk devices for glucose management. </span></p> <p><strong><span>Materials and Methods: </span></strong><span>We<span> identified interventional and observational studies evaluating the </span>efficacy and safety of 8 automated insulin delivery (AID) systems, 2 implantable insulin pumps, and 3 implantable continuous glucose monitoring (CGM) devices.<span> </span></span><span>We meta-analysed randomized controlled trials (RCTs) comparing AID systems with other treatments.</span></p> <p><strong><span>Results:</span></strong><span> 99 studies published from 2009&ndash;2022 were included, comprising 83 on AID systems, 6 on insulin pumps, and 10 on CGM; 43% reported industry funding;30% were pre-market; 45% had a comparator group. 33% were RCTs, 25% non-randomized trials, and 41% observational studies. Median sample size was 52 (interquartile range 25&ndash;111), age 37.8 years (17&ndash;45.5), and study duration 13 weeks (4.5&ndash;26). AID systems lowered HbA1c by 0.3 percentage points (absolute mean difference [MD]=-0.3; 9 RCTs; I<sup>2</sup>=85%) and increased time in target range for sensor glucose level by 10.5 percentage points (MD=10.5; 14 RCTs; I<sup>2</sup>=89%). 69% of studies reported on at least one safety outcome.</span></p> <p><strong><span>Conclusions:</span></strong><span> High-risk devices for glucose monitoring or insulin dosing, in particular AID systems, improve glucose control safely but evidence on diabetes-related end organ damage is lacking due to short study durations. Methodological heterogeneity highlights the need for d<span><span>eveloping standards for future pre- and post-market investigations of diabetes-specific high-risk medical devices.</span></span></span></p>

opencc-by-4.0Mar 2024View details →
ClinicalTrials.gov40/100

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

ClinicalTrials.gov study NCT01131312. IPD Sharing: YES. Countries: 1. Publications: 3.

controlledIPD-YESFeb 2026View details →
zenodo36/100

Clinical Trial Subject Management System (CTSMS)

<p>CTSMS is mainly composed of three stages: operational management pre-configuration, subject recruitment, and subject visit management. The features included in the operational management pre-configuration stage include study participant assignments, protocol configuration, e-CRF form design, rule configuration, and global control over the access rights and visitation rules of subjects under the study project. The main features of the subject recruitment stage of the system include subject recruitment, subject violation verification, subject lists, and subject global labeling, to realize the registration of subjects under the corresponding study project, status labeling, and visualization.</p>

opencc-by-4.0Jan 2022View details →
zenodo36/100

Supporting information for: The Time Requirements for Primary Care Consultations: Initial Sick Child Visits in Low- and Middle-income Countries Using the Integrated Management of Childhood Illness (IMCI) Clinical Algorithm

<p>Few studies have examined the time required for primary care consultations; none have focused on sick child visits in low- and middle-income countries (LMICs). This project begins to fill that gap by providing evidence-based estimates of the time needed for initial visits with under-five infants and children at public or not-for-profit facilities in countries using the Integrated Management of Childhood Illness (IMCI) clinical algorithm.</p> <p>Estimates of the mean expected duration of IMCI consultations require (a) classification profiles, i.e., tabulations of the gold standard health issues presented by patients less than 5 years old; (b) lists of the tasks included in applicable versions of the IMCI algorithm and the conditions that elicit them, and (c) an estimate of the time needed to perform tasks with no pre-defined minimum duration. The latter requires, in addition to classification profiles, information on rates of task performance and the mean observed duration of consultations.</p> <p>The IMCI clinical algorithm and the research surrounding it provide unusually rich sources of such information. Developed in the mid 1990s by the World Health Organization and the United Nations Children&rsquo;s Fund, the IMCI algorithm seeks to reduce child mortality in LMICs by improving the technical quality of primary care services. For infants less than 2 months old, the algorithm focuses on bacterial infections, feeding problems, low weight, and, in some versions, jaundice. For children 2-59 months old, the foci include acute respiratory infections, especially pneumonia; diarrhea; fevers, especially malaria and measles; malnutrition, and anemia. Immunization status is a concern for both age groups. The algorithm provides a scheme to classify the health issues with which infants and children present, an array of tasks providers may be expected perform, and criteria by which tasks are elicited. Research on the design and utility of the algorithm, its effects on provider performance, and related topics furnishes data on the prevalence of gold standard IMCI classifications in a variety of patient populations. In some cases, it also enables one to calculate the time required to perform tasks.</p> <p>I found such information by searching MEDLINE, the database of the International Network for Rational Use of Medicines, the websites of the WHO and its regional offices, GOOGLE, and GOOGLE SCHOLAR using search terms such as &lsquo;Integrated Management of Childhood Illness&rsquo;, &lsquo;observational&rsquo;, &lsquo;prospective&rsquo;, &lsquo;classification&rsquo;, &lsquo;clinical signs&rsquo;, &lsquo;health facility survey&rsquo;, and &lsquo;validity&rsquo;. I also reviewed studies that cited a qualified study and, conversely, material included in the bibliographies of qualified studies.</p> <p>The supplemental information files contain the following:</p> <p>WORKBOOK S1_STUDIES USED</p> <p>Lists features of, and sources for, the studies used to construct classification profiles and to estimate the time required to perform the average task with no predefined minimum duration. With 2 exceptions (see below, DATA S1 and DATA S2), all the studies have been published or are readily available on the internet. None of the data can be used to identify individuals.</p> <p>DATA S1_REPORT OF THE HEALTH FACILITY SURVEY IN BOTSWANA, 2007-08 and DATA S2_REPORT OF THE HEALTH FACILITY SURVEY IN TANZANIA, 2003</p> <p>PDF files of Health Facility Survey reports that were found on the internet but have since been taken down.</p> <p>DATA S3_BURKINA FASO CHART BOOKLET, 2015</p> <p>PDF provided <span>Drs. Sophie Sarrassat (London School of Hygiene and Tropical Medicine) and Serge M. A. Somda (Universit&eacute; Nazi BONI).</span></p> <p>WORKBOOK S2_CLASSIFICATION PROFILES: INFANTS; WORKBOOK S3_CLASSIFICATION PROFILES: CHILDREN IN UPPER MIDDLE-INCOME COUNTRIES; WORKBOOK S4_CLASSIFICATION PROFILES: CHILDREN IN LOWER MIDDLE-INCOME COUNTRIES (I); WORKBOOK S5_CLASSIFICATION PROFILES: CHILDREN IN LOWER MIDDLE-INCOME COUNTRIES (II), and WORKBOOK S6_CLASSIFICATION PROFILES: CHILDREN IN LOW INCOME COUNTRIES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p> <p>The design of the worksheets in these workbooks is described in TEXT S1_NOTES OF THE CONSTRUCTION OF CLASSIFICATION PROFILES (see below).</p> <p>WORKBOOK S7_IMCI CLINICAL TASKS</p> <p>Lists the clinical tasks provided by relevant IMCI algorithms for the care of infants and children. Consists of 6 worksheets covering mandatory tasks, conditional assessments, and treatment and counseling tasks for infants and children.</p> <p>WORKBOOK S8_MINUTES PER TASK WITH NO MINIMUM DURATION</p> <p>Provides estimate of the mean time required to perform a task with no minimum duration for each of 7 populations for which the required data are available, corrected, where necessary, for the effect of an observer on the rate and pace of task performance. Also provides a geometric mean for all 7 populations.</p> <p>TEXT S1_NOTES ON METHODOLOGY</p> <p>WORD document describing the steps involved in estimating the expected durations of consultations.</p> <p>TEXT S2_NOTES OF THE CONSTRUCTION OF CLASSIFICATION PROFILES</p> <p>WORD document describing the steps involved in constructing each profile, problems encountered, and how they were solved.</p> <p>TEXT S3_NOTES ON THE IDENTIFICATION OF IMCI CLINICAL TASKS</p> <p>WORD document describing the standards used in identifying clinical tasks in IMCI algorithms.</p> <p>TEXT S4_NOTES ON THE ESTIMATION OF MINUTES PER TASK WITH NO MINIMUM DURATION</p> <p>WORD document describing the steps involved in estimating the mean time required to perform a task with no predefined minimum duration, problems encountered, and how they were solved.</p>

opencc-by-4.0Oct 2024View details →
zenodo36/100

Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology

<p>This compressed ZIP file includes three components</p> <p>The Full Guideline Document (FINAL COPY) for the&nbsp;<strong>2022 Saudi Guideline for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children</strong></p> <p>In addition to two guideline reporting checklists to ensure the quality of this adoloped guideline:-</p> <p><strong>1- AGREE Reporting Checklist</strong></p> <p><strong>2- RIGHT-Ad@pt Checklist</strong></p> <p>As a supplementary to the submitted article entitled:_</p> <p><strong>Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology</strong></p>

opencc-by-4.0Apr 2023View details →
zenodo36/100

How Safe and Technical Is Modified Dunn Osteotomy in the Management of Patients with SCFE: A Clinical Trial with Short Term Followup

<p>This is the master datasheet&nbsp;used to support the findings of this study and Video 1 containing intraoperative scenes to show bleeding femoral head</p>

opencc-by-4.0May 2023View details →
ClinicalTrials.gov36/100

LINX Reflux Management System Clinical Study Protocol

ClinicalTrials.gov study NCT00776997. IPD Sharing: Not stated. Countries: 2. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

B Vitamin Supplementation to Chiropractic Management of Chronic LBP: Pilot Clinical Trial (VCLBP)

ClinicalTrials.gov study NCT06576739. IPD Sharing: YES. Countries: 1. Publications: 10.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye

ClinicalTrials.gov study NCT04498468. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Clinical Risk Score for Early Management of TB in Uganda

ClinicalTrials.gov study NCT05122624. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis

ClinicalTrials.gov study NCT02022826. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

ClinicalTrials.gov study NCT07232017. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial

ClinicalTrials.gov study NCT02927691. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders

ClinicalTrials.gov study NCT00861198. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Randomized Clinical Trial of Alcohol Care Management

ClinicalTrials.gov study NCT00419315. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Home-based tDCS and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms

ClinicalTrials.gov study NCT04375072. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Ar

ClinicalTrials.gov study NCT01177553. IPD Sharing: Not stated. Countries: 1. Publications: 32.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection

ClinicalTrials.gov study NCT01596283. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Stu

ClinicalTrials.gov study NCT06958627. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

CloudConnect: Predictive And Retrospective Clinical Decision Support For Chronic Disease Management

ClinicalTrials.gov study NCT03676465. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.